Биология ва тиббиёт муаммолари 2023 №5.1 (149)

Тема статьи

ЧАСТОТА СЛУЧАЙНОЙ НАХОДКИ РАКА В ГИСТОЛОГИЧЕСКОМ МАТЕРИАЛЕ ПОСЛЕ ТРАНСУРЕТРАЛЬНОЙ РЕЗЕКЦИИ ПРОСТАТЫ И НАШ КЛИНИЧЕСКИЙ ПОДХОД К ЭТИМ ПАЦИЕНТАМ: РЕТРОСПЕКТИВНЫЙ АНАЛИЗ (80-83)

Авторы

Закиров Алишер Камилович, Рахмонов Ойбек Мухаммадмуйдинович, Жумаев Азиз Камолович, Джураев Фаррух Миржалолович

Учреждение

TASHKENT MEDICAL PARK by Urologic Complex, Республика Узбекистан, г. Ташкент

Аннотация

В статье представлены результаты исследования заболеваемости раком простаты, перенесших трансуретральную резекцию простаты (ТУР) из-за инфравезикальной обструкции.

Ключевые слова

случайный рак предстательной железы; трансуретральная резекция; ПСА.

Литературы

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2008) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424 2. Mod Pathol 24:58–63 4. Perera M, Lawrentschuk N, Perera N, Bolton D, Clouston D (2015) Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years. Prostate Int 3. Saleh AM, Fooladi MM, Nustas WP, et al (2015). Enhancing knowledge, beliefs, and intention to screen for prostate cancer via different health educational interventions: a literature review. Asian Pac J Cancer Prev, 16, 5137-41. 4. Esfahani M, Ataei N, Panjehpour M (2015). Biomarkers for evaluation of prostate cancer prognosis. Asian Pac J Cancer Prev, 16, 2601-11 5. Jones JS, Follis HW, Johnson JR (2009). Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis; 12, 57-60. 6.Lilja H. A kallikrein like serum protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest1985;76:1899–903. 7.Morote J, Lopez M, Encabo G, de Torres IM. Effect of inflammation and benign prostatic enlargement on total andfree serum prostate specific antigen. Eur Urol 2000;37:537–40. 8. Abedi AR, Ghiasy S, Fallah-Karkan M, Rahavian A, Allameh F (2020) The management of patients diagnosed with incidental prostate cancer: narrative review. Res Rep Urol 12:105–109. 9.Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology2000;55:791–5. 10.Tombal B, De Visccher L, Cosyns JP, Lorge F, Opsomer R, Wese FX, et al. Assessing the risk of unsuspected prostatecancer in patients with benign prostatic hypertrophy: a 13-yearretrospective study of the incidence and natural history of T1a-T1b prostate cancers, BJU Int 1999;84(9):1015–20. 11.Mai KT, Isotalo PA, Green J, Perkins DG, Morash C, Collins JP. Incidental prostatic adenocarcinomas and putativepremalignant lesions in TURP specimens collected before andafer the introduction of prostrate-specific antigen screening,Arch Pathol Lab Med 2000;124(10):1454–6. 12. Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA et al (2003) Distribution of infammation, pre-malignant lesions, incidental carcinoma in histologically confrmed benign prostatic hyperplasia: a retrospective analysis. Eur Urol 43:164–175 13.Yoo C, Oh CY, Kim SJ, Kim SI, Kim YS, Park JY, et al. Preoperative clinical factors for diagnosis of inci-dental prostatecancer in the era of tissue ablative surgery for benign prostatichyperplasia: A Korean multi-center review. Korean J Urol2012;53(6):391–5. 14.Khan MA, Shah HU, Gul M, Qayyum A. Fre-quency of incidentally diagnosed prostate carcinoma in transurethrally resected prostatespecimens. J Postgrad Med Inst 2017;31(4):357–60. 15.Trpkov K1, Tompson J, Kulaga A, Yilmaz A. How much tissue sampling is required when unsuspected minimal prostatecarcinoma is identified on transurethral resection? Arch PatholLab Med 2008;132(8):1313–6. 16.Varghese J, Kuruvilla MP, Mehta N, Rathore RS, Babu M, Bansal B, et al. Incidentally Detected Adenocarcinoma Prostatein Transurethral Resection of Prostate Specimens: a HospitalBased Study from India. Asian Pac J Cancer Prev 17(4), 2255–58. 17.Tapa N, Shris S, Pokharel N, Tambay YG, Kher YR, Acharya S. Incidence of carcinoma prostate in transurethral resectionspecimen in a teaching hospital of Nepal. Journal of LumbiniMedical College 2016;4(2):77–9. 18. Yoo C, Oh CY, Kim SJ, Kim SI, Kim YS, Park JY, et al. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review. Korean J Urol. 2012;53:391–395. 19. Zigeuner RE, Lipsky K, Riedler I, Auprich M, Schips L, Salfellner M, et al. Did the rate of inci-dental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology. 2016;62:451–455 20. Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD et al (2005) Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174:2181–2185 21. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33. Erratum in: CA Cancer J Clin. 2021; 71:359